XueqingYu Guangzhou, ChinaChina

Wcn26 Post edited Speaker Card

29 March 2026

Time	Session

9:25 a.m. 10:55 a.m.	ISN - APSN Joint Session IgA Nephropathy Study: Current and Perspective XueqingYu Speaker yuxueqing@gdph.org.cnChina Optimizing Management of Lupus Nephritis – The Clinical, The Bytes and The Bench DesmondYap Speaker desmondy@hku.hkHong Kong, China Seeds of Change: Growing Together – The Collaborative Journey of APSN-YNC KornchanokVareesangthip Speaker kornchanok.ploy@gmail.comThailand Genetics of Chronic Kidney Disease in East Asians YukaSugawara Speaker ysuga-tky@m.u-tokyo.ac.jpJapan Q&A 303	HIT! High Impact Clinical Trials 2 - New Insights Into Ongoing Trials AdeeraLevin Chair alevin@providencehealth.bc.caCanada Andrea Viecelli Chair andrea.k.viecelli@gmail.comSwitzerland RobertoPecoits-Filho Chair roberto.pecoits@arborresearch.orgUnited States ASPIRE (Aspirin in Dialysis PTS/ China): Large Pragmatic Trial XueqingYu Speaker yuxueqing@gdph.org.cnChina RESOLVE (NA CONCENTRTION IN DIALYSIS POPULATIONS: GLOBAL): CLUSTER RANDOMIZED TRIAL MegJardine Speaker meg.jardine@sydney.edu.auAustralia VOICE ShuchiAnand Speaker sanand2@stanford.eduUnited States TEST PD JosephineChow Speaker Josephine.Chow@health.nsw.gov.auAustralia Renal Life Cycle HiddoLambers Heerspink Speaker H.J.Lambers.Heerspink@umcg.nlNetherlands Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-proven Primary Glomerular Diseases: Multi-center, Multi-arm and Multi-stage- the Story So Far Selvin Sundar RajMani Speaker selvinsr@gmail.comIndia Q&A Main Hall